We are pleased to announce our latest news to you.
After an already successful partnership on the Patient Engagement Guide, admedicum has officially joined HollandBIO, an interest group of biotech companies in the Netherlands. admedicum and HollandBIO share the idea that a society in which biotechnology makes a maximum contribution to health, sustainability and economic growth should involve patients. We are happy to become members and benefit from the strong network of HollandBIO and the quality of their meetings and conferences.
The healthcare system of the future sees the patient at the center of events. It talks to patients and not about patients, involving them in a meaningful way when developing new treatments. Communication is open and transparent, and there is joint decision-making with all stakeholders. In tomorrow’s healthcare system, trust and mutual respect are key elements, while any conflicting interests that may arise are honestly declared.
admedicum recently attended the HTAi 2019 meeting in Cologne, Germany entitled, “HTA beyond 2020: Ready for the New Decade?” At admedicum, we believe patient involvement in HTA is crucial for making the right decisions because health technology is FOR THE PATIENTS. We took the opportunity of other stakeholders being in Cologne to co-host a PEGASUS Networking Event to discuss the same topic as this blog with a group of diverse stakeholders including patient-representatives from several different disease-areas.
Since its release in 2018 the Patient Engagement Guide (PEG) has served subscribers from the pharmaceutical and biotech industry all over the world in their mission to incorporate Patient Engagement into their daily business.
Months have passed and admedicum has accompanied exciting projects, met inspiring people, participated in glowing discussions – all evolving around how to bring patients’ needs and industry’s’ potential closer together.
We are excited to share some of what we have learned and gather our experiences in the2.0 version of the PEG.
You are a manager in the healthcare industry or work for a statutory health insurance that develops or reimburses innovative therapy concepts? Would you like to know more about the implementation of the GSAV guidelines in practice?
Then this course is designed for you!